Search

everythinglearnresearchcommunity

for

Search:↓

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Hair loss treatment caused more hair loss in a man.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.